Am J Transplant, Volume 19, Suppl 3 Archives - Page 27 of 214 - ATC Abstracts

2019 American Transplant Congress
Alemtuzumab versus Anti-Thymocyte Globulin Induction in the Setting of Immediate Post-Renal Transplant Acute Tubular Necrosis in an Urban, Minority Patient Population
K. Tejani, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: Post-renal transplant (RTx) delayed graft function (DGF) or slow graft function (SGF) increase the risk of rejection and impair allograft function. Lymphocyte depleting induction…
2019 American Transplant Congress
Panel Reactive Antibody Stratification as a Guide to Induction Selection in Deceased-Donor Kidney Transplantation: Impact of Clinical Practice on Outcomes
H. Ibrahim¹, J. Gregg¹, K. Alquadan¹, U. Akanit², K. L. Womer¹, A. H. Santos¹
¹Medicine, University of Florida, Gainesville, FL, ²Ubon Ratchathani University, Ubonratchathani, Thailand
*Purpose: We aimed to determine the outcomes associated with anti-thymocyte globulin (ATG), alemtuzumab (ALM) or interleukin-2 receptor antagonist (IL2-RA) induction in adult deceased-donor (DD) kidney…
2019 American Transplant Congress
Kidney Transplantation in Patients with Neurogenic Bladder
Z. Jurekovic, M. Knotek
Clinical Hospital Merkur, 10000 Zagreb, Croatia
*Purpose: Neurogenic bladder is a condition associated with high incidence of urinary tract infections (UTI). Infections in immunocompromised patients can be life-threatening and result in…
2019 American Transplant Congress
Kidney Volumes in Healthy Donors – Does Size Really Matter?
F. R. Schwartz¹, B. I. Shaw², F. Vernuccio¹, F. Rigiroli¹, F. Gonzalez¹, R. Lerebours³, K. Ravindra², D. Marin¹
¹Radiology, Duke University, Durham, NC, ²General Surgery, Duke University, Durham, NC, ³Biostatistics and Bioinformatics, Duke University, Durham, NC
*Purpose: To assess the relationship between craniocaudal renal diameters and renal volumes, as well as the frequency of appropriate renal selection for transplant using conventional…
2019 American Transplant Congress
Two-Year, Single Center, Retrospective Review of Herbal Supplement Use in Living Kidney Donors
N. Persun¹, D. Johnson¹, A. Leonberg-Yoo², J. Bahrainwala², P. P. Reese², D. M. Collins³, M. Houston³, A. Naji⁴, J. Trofe-Clark¹
¹Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA, ³Hospital of the University of Pennsylvania, Philadelphia, PA, ⁴Surgery, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Herbal supplement use in the evaluation phase of live kidney donors (LKD) poses challenges to providers. No formal management guidelines exist. Herbal supplements can…
2019 American Transplant Congress
Standardized Pain Management Post Donor Nephrectomy Results in Decreased Length of Stay
N. Alvey¹, B. Hohoff², M. Brokhof¹, N. Kenyon¹, E. Hollinger³
¹Pharmacy, Rush University Medical Center, Chicago, IL, ²Transplant, Rush University Medical Center, Chicago, IL, ³Surgery, Rush University Medical Center, Chicago, IL
*Purpose: Laparoscopic donor nephrectomy has reduced the burden associated with open surgery, but a significant percentage of donors still suffer from postoperative pain. It is…
2019 American Transplant Congress
Mitigating Racial and Gender Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-Center Kidney Chain
M. N. Mustian, V. Kumar, K. Stegner, D. Mompoint-Williams, M. Hanaway, M. H. Deierhoi, C. Young, B. Orandi, D. Anderson, P. A. MacLennan, R. D. Reed, B. A. Shelton, D. Eckhoff, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Disparities in access to living donor kidney transplantation (LDKT) exist among minorities and women and may be partially explained by antigen sensitization secondary to…
2019 American Transplant Congress
Allograft Quality Impacts Simultaneous Liver Kidney Transplant Survival Outcomes in Recipients That Undergo Liver Re-Transplantation
J. Reyes, M. Eerhart, C. Blanton, P. Chlebeck, E. Polyak, Y. Yankol, L. Fernandez
Department of Surgery, University of Wisconsin - Madison, Madison, WI
*Purpose: The only effective therapeutic strategy for irreversible liver graft failure is re-transplantation. The impact of liver and kidney quality in secondary SLK (sSLK) survival…
2019 American Transplant Congress
Multidisciplinary Practitioner Perspectives on Cardiovascular Disease Guideline Interventions in Liver Transplant Recipients
M. Kosirog¹, L. Adamski¹, A. Daud², D. Finn², D. Gregory¹, D. M. Lloyd-Jones³, J. L. Holl⁴, L. B. VanWagner⁵
¹Medicine-GI & Hepatology, Northwestern University, Chicago, IL, ²Center for Healthcare Studies, Northwestern University, Chicago, IL, ³Medicine-Cardiology and Preventive Medicine, Northwestern University, Chicago, IL, ⁴Pediatrics & Center for Healthcare Studies, Northwestern University, Chicago, IL, ⁵Medicine-GI & Hepatology and Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in liver transplant recipients (LTRs). However, there is a lack of LT-specific CVD clinical practice…
2019 American Transplant Congress
Totally Robotic Donor Hepatectomy: Feasibility And Early Outcomes
Y. Cheah, C. J. Simon, W. D. Lewis, R. L. Jenkins, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: Robotic surgery is emerging as a surgical technique to enable resection of the liver using minimally invasive techniques; however, very few living donor liver…